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Purpose: Interfraction tumor setup variations in radiotherapy are often reduced with image guidance
procedures. Clinical target volume (CTV)–planning target volume (PTV) margins are then used to
deal with residual errors. We have investigated characterization of setup errors in patient populations
with explicit modelling of occurring interfraction time trends.
Methods: The core of a “trendline characterization” of observed setup errors in a population is a dis-
tribution of trendlines, each obtained by fitting a straight line through a patient’s daily setup errors.
Random errors are defined as daily deviations from the trendline. Monte Carlo simulations were per-
formed to predict the impact of offline setup correction protocols on residual setup errors in patient
populations with time trends. A novel CTV-PTV margin recipe was derived that assumes that system-
atic underdosing of tumor edges in multiple consecutive fractions, as caused by trend motion, should
preferentially be avoided. Similar to the well-known approach by van Herk et al. for conventional
error characterization (no explicit modelling of trends), only a predefined percentage of patients (gen-
erally 10%) was allowed to have nonrandom (systematic + trend) setup errors outside the margin.
Additionally, a method was proposed to avoid erroneous results in Monte Carlo simulations with
setup errors, related to decoupling of error sources in characterizations. The investigations were
based on a database of daily measured setup errors in 835 prostate cancer patients that were treated
with 39 fractions, and on Monte Carlo–generated patient populations with time trends.
Results: With conventional characterization of setup errors in patient populations with time trends,
predicted standard deviations of residual systematic errors (Rres) after application of an offline cor-
rection protocol could be underestimated by more than 50%, potentially resulting in application of
too small margins. With the new trendline characterization this was avoided. With the novel CTV-
PTV margin recipe with an allowed 10% of patients having nonrandom errors outside the margin, the
observed percentage was 10.0%  0.2%. When using conventional characterization of errors and the
van Herk margin recipe, on average 58.0%  24.3% of patients had errors outside the margin, while
10% was prescribed. For populations with no time trends, the novel recipe simplifies to the generally
applied M ¼ 2:5Rþ 0:7r formula proposed by van Herk et al.
Conclusions: In populations with time trends in setup errors, the use of trendline characterizations
in Monte Carlo simulations for establishment of residual errors after a setup correction protocol can
avoid application of erroneous margins. The novel margin recipe can be used to accurately control
the percentage of patients with nonrandom errors outside the margin. In case of daily image guidance
of patients with multiple targets with differential motion, the recipe can be used to establish margins
for the targets that are not the primary target for the image guidance (e.g., nodal regions). Probabilis-
tic planning might be improved by using trendline characterization for modelling of setup errors.
Population analyses of interfraction setup errors need to take into account potential time trends.
© 2019 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of American
Association of Physicists in Medicine. [https://doi.org/10.1002/mp.13919]
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1. INTRODUCTION
In fractionated radiotherapy, tumor setup errors at the linac
are often mitigated with image-guided corrections.1–3 For
planning, a Clinical target volume (CTV)–planning target
volume (PTV) margin4,5 is used to cope with residual errors.
Both for estimating the expected impact of a setup correction
protocol on treatment accuracy and for establishment or
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validation of margin recipes, Monte Carlo (MC) simulations
may be performed using a characterization of the setup errors
in the patient population.
It is generally assumed that setup errors occurring in a
fractionated treatment of a patient can be described with nor-
mal distributions and that they can be characterized by the
mean (systematic) error during the treatment and day-to-day
variations around the mean (random errors). Observed sys-
tematic and random errors are used to derive population
parameters that characterize the error distributions along the
principal directions, that is, anterior–posterior, superior–infe-
rior, left–right. In this paper, this much applied characteriza-
tion of setup errors in a patient population is designated as
the “conventional characterization”6 (see Appendix A for
equations).
Daily tumor setup relative to the treatment unit isocenter
may gradually change during a fractionated treatment, result-
ing in an interfraction time trend in setup.7–14 Existence of
interfraction time trends has been reported by several groups
for different cancer sites. El Gayed et al.7 reported trend
motion of 4–11 mm for 2 rectal and 3 prostate patients out of
10 patients per cancer site. Hanley et al.8 found statistically
significant trends in 10 out of the 50 prostate patients with a
range of 2–7 mm. Stroom et al.9 compared 15 prostate
patients treated in prone position with 15 treated in supine
position and found time trends in rectum diameter and pros-
tate translations. van der Heide et al.10 investigated prostate
treatment with fiducials for 453 patients receiving a 35 frac-
tion treatment. They found total motion of 3.1 mm in AP and
1.7 mm in SI direction. Namysl-Kaletka et al.11 analyzed 57
patients with gastric cancer treated with 25 or 28 fractions.
They reported 1 and 1.6 mm total trend motion in LR and SI
direction, respectively. Gangsaas et al.12 showed caudal trend
motion of up to 11 mm (average 3.2 mm) for 30 patients with
laryngeal cancer. Penninkhof et al.13 showed more than
5 mm total tumor bed trend motion in 20% of breast cancer
patients treated with a simultaneously integrated boost tech-
nique.
Such time trends are not explicitly considered in the con-
ventional characterization. Rather, they are implicitly treated
as part of the random error. However, a time trend motion is
clearly deterministic, with a gradual, cumulative shift of the
tumor in the 3D dose distribution during the fractionated
treatment. This deterministic motion may have an impact on
the performance of offline setup correction protocols, with
corrections based on setup measurements in the first frac-
tions. Not explicitly accounting for time trends in the CTV-
PTV margin may result in underdosage of tumor edges in
substantial numbers of consecutive fractions. For example,
for a patient with no systematic setup error, a time trend in
LR direction can result in a systematic underdose in the left
tumor edge in each of the first 50% of fractions, and an
underdose in the right tumor edge in all subsequent frac-
tions. Existing rather simple TCP models suggest that the
order of fractions with underdose would not be important.
However, to the best of our knowledge there is no evidence
that systematically underdosing the same part of the tumor
in many fractions at a row, and compensating it with ade-
quate dose delivery in the other fractions, would be equiva-
lent to a random ordering of fractions with underdose and
adequate dose. There are many examples in the radiotherapy
literature showing that time patterns in dose delivery can
indeed matter.
In this paper, we investigated the explicit modelling of
interfraction time trends in tumor setup errors, using so-
called trendline characterizations of setup errors observed in
patient populations. Trendline characterizations were com-
pared to conventional characterizations regarding accuracy of
Monte Carlo (MC) predicted residual setup errors in case a
no-action-level (NAL) protocol2 or an extended NAL (eNAL)
protocol3 was used for setup corrections. We developed a
novel CTV-PTV margin recipe that assumes that determinis-
tic underdosing of tumor edges due to time trends should
preferentially be avoided. The approach was highly similar to
van Herk’s derivation of his well-known margin recipe,4 aim-
ing at equality of the recipes in the limit of no time trends in
the population.
The investigations included synthetic patient populations
with time trends and a database with daily setup errors mea-
sured in a large population of prostate cancer patients that
experienced time trends (“Erasmus database”).
2. MATERIALS AND METHODS
2.A. Trendline characterization of setup errors to
model interfraction time trends in setup errors
In contrast to a conventional characterization of setup
errors in a population (Appendix A), a trendline characteriza-
tion explicitly models occurring time trends.3 To this pur-
pose, for each patient p the setup errors in the fractionated
treatment along each of the principal axes are characterized
with a linear trendline, fitted through the daily measured
setup errors (see Fig. 1), and defined by the slope ap (mm/
fraction), and middle position mp (mm). The latter is the
setup error half-way the fractioned treatment according to the
fitted trendline, that is, the mean of the trendline tumor posi-
tions in fraction 1 and the last fraction F. It can be easily pro-
ven that this mp equals the mean setup error in the
fractionated treatment as used in the conventional characteri-
zation. In the remainder of this paper, setup errors according
to the trendline are designated “trendline errors.” Daily devia-
tions from the trendline are now defined as the random errors
(see Fig. 1). This leads to the following parameters defining a
trendline characterization, with M and R also used in a con-
ventional characterization:
• the overall mean setup error in the population
M ¼
P
p mp
N
(1)
with mp the mean setup error of patient p in the fractionated
treatment
Medical Physics, 47 (2), February 2020
332 Gi _zynska et al.: Coping with interfraction time trends in tumor setup 332
• the standard deviation describing the distribution of sys-
tematic (i.e., mean) setup errors in the population
R ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
p
mp M
 2
N  1
vuut (2)
• the population mean of the trendline slopes:
Ma ¼
P
p ap
N
(3)
with ap the trendline slope calculated for patient p, and N
the number of patients in the population
• the standard deviation describing the interpatient varia-
tion in the trendline slopes:
Ra ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
p
ap Ma
 2
N  1
vuut (4)
• the population standard deviation describing random
errors relative to the trendlines (see also Fig. 1):
r
0 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
p
SD02p
N
s
(5)
with SD
0
p the standard deviation of random errors relative
to the trendline observed for patient p
• the standard deviation describing the variation of SD0p
in the population15:
SD
0
SD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X
p
SD0p  SD0p
 2
N  1
vuut
(6)
2.B. The Erasmus database with prostate setup
errors
Daily setup errors of 835 prostate cancer patients treated
between November 2007 and May 2017 at the Erasmus MC
Cancer Institute with 39 fractions of 2 Gy were used to build
the database. Setup deviations in these patients were mea-
sured with kV/MV crossfire imaging of four implanted gold
markers.10,16–18 Setup errors were quantitated as marker cen-
ter-of-mass displacements along the three principal direc-
tions, realizing that the mechanism for motion could in some
cases also be rotations or deformations. The database was
filled with setup errors that would have occurred in case no
correction protocol would have been applied, that is, applied
(a priori) setup corrections prior to imaging were subtracted
from measured setup errors.
2.C. Synthetic patient populations with setup errors
Synthetic populations were created by choosing concrete
values for the parameters in a trendline characterization and
then using a MC approach to randomly create 39 fraction
treatments for 10 000 patients (see Section 2.D for details).
Parameters used for generation of synthetic setup errors along
the three principal axes were: M ¼ 0, R 2 1; 2; 3; 4f g mm, r0
2 1; 2; 3f g mm, SD0SD ¼ 0:75 mm, Ra 2 0; 0:05; 0:1; 0:15f g
mm=fraction, andMa 2 0;0:05;0:1f gmm=fraction.
Simulations of the NAL and eNAL protocol (Sections 2.E
and 3.B) were performed per principal direction, in line with
the clinical application of these protocols.
Two types of synthetic populations were created for
investigations on the CTV-PTV margin: isotropic (using
the same distributions of trendline parameters for all three
directions) and anisotropic (with different, randomly cho-
sen distributions of trendline parameters for the three
directions). By including all possible combinations of pre-
selected parameters (above), a total number of 144 isotro-
pic populations was generated. For generating the
anisotropic populations, the same parameters were used as
for isotropic populations but randomly chosen for each of
principal directions (without replacements) resulting also
in 144 anisotropic populations.
2.D. Monte Carlo (MC) generation of setup errors in
a patient population
As described above, setup errors in a population are gen-
erally described by a conventional characterization. As dis-
cussed in this paper, alternatively, a trendline
characterization can be used if time trends are (potentially)
present. However, in both cases, when using the characteri-
zation parameters in a MC experiment for generating a
FIG. 1. Setup errors for an example patient with a time trend. The straight
dashed line is the fitted trendline. Each fraction the total setup error (blue
dot) is the sum of the error according to the dashed trendline (denoted as
“trendline error,” see black arrow as example) and the random error defined
as the daily deviation from the setup according to the trendline (see red
arrow). MDp is the patient’s maximum trendline setup error, used for calcula-
tion of clinical target volume (CTV)–planning target volume (PTV) margin
for nonrandom errors (Section 2.F). mp is the trendline error in the middle of
the fractionated treatment which equals the systematic tumor setup. ap is the
trendline slope, F is the total number of fractions. [Color figure can be
viewed at wileyonlinelibrary.com]
Medical Physics, 47 (2), February 2020
333 Gi _zynska et al.: Coping with interfraction time trends in tumor setup 333
population of, for example, 10 000 new patients, the charac-
terization parameters for these 10 000 patients will not be
equal to the original parameters. The problem can be illus-
trated for a conventional characterization using a simple
example: the random setup errors for a particular patient in
the 39 fractions treatment are randomly drawn from a gaus-
sian distribution G 0; SDp
 
, with SDp randomly drawn from
the distribution G r; SDSDð Þ. Due to the finite number of
fractions (39), the mean of the drawn ‘random’ errors for
the patient will in general not be equal to zero, that is, effec-
tively the drawn errors are not completely random as they
have a systematic component. Basically, this is caused by
de-coupling of error sources in the characterization. Some-
thing very similar occurs with a trendline characterization:
due to the finite number (F = 39) of drawn random errors,
both the mean setup error of the patient and the slope of the
trendline will in general be different from the drawn mp and
ap, respectively. To avoid errors in the MC simulations, cor-
rections described in Appendix B were always performed
for drawn random errors.
2.E. NAL and eNAL ofﬂine protocols for correction
of interfraction setup errors
The NAL2 and eNAL3 protocols are briefly summarized
in Appendix C. In this study, we investigated for conventional
and trendline characterizations the accuracy of MC simulated
predictions of residual systematic setup errors for the NAL
and eNAL protocols in patient populations with time trends.
For both characterizations, Rres, the standard deviation
describing the population residual systematic errors after
NAL or eNAL was established.
2.F. A novel CTV-PTV margin recipe to account for
time trends in setup errors
For the derivation of the margin recipe MPTV ¼
2:5Rþ 0:7r, based on the conventional characterization
of setup errors, the margins for systematic and random
setup errors (MPTVsys ¼ 2:5R and MPTVrand ¼ 0:7r, respectively)
were independently established. Similarly, in the proposed
margin recipe for a population with time trends, the mar-
gin contribution related to the trendlines, defined by a
slope and a middle position (the latter equaling the
patient’s systematic setup error see Section 2.A), and the
contribution from the random errors around the trendlines
are treated separately (see Fig. 1). Actually, MPTVrand ¼ 0:7r
in the van Herk recipe is replaced by MPTVrand ¼ 0:7r0 [see
Eq. (5)], while a new term, MPTVtrend, is derived for coping
with the trendline errors to replace the MPTVsys term. Equiv-
alent to the work by van Herk et al.,4 this new term is
derived by requiring that for 90% of patients, the full
CTV is within the PTV for 100% of the (nonrandom)
trendline errors.
The margin component related to trendline errors, MPTVtrend,
is a 3D vector. In order to calculate its components, MPTVtrend;i,
for each principal direction, i, a procedure similar to that used
by van Herk et al.4 for deriving MPTVsys;i ¼ 2:5  Ri is used,
assuming for each direction a spherical 3D situation. In other
words, for establishment of MPTVtrend;i it is assumed that the dis-
tributions of trendline errors for all three directions, k, are the
same as for direction i. This procedure would be performed
for each axis i based on the population parameters: Mi, Ri,
Ma;i and Ra;i [see Eqs. (1), (2), . . ., for definitions].
i. randomly select for a large number of patients, p, the
trendlines, that is, select mp;k and ap;k for the three prin-
cipal directions, k, from the gaussian distributions
G Mi;Rið Þ and G Ma;i;Ra;i
 
;
ii. determine for each patient, p, the maximum setup devi-
ations following from the trendlines for the three prin-
cipal directions as MDp;k ¼ jmp;kj þ F12 jap;kj (see
Fig. 1, note: the jmp;kj; andjap;kj distributions are
folded-Gaussians);
iii. determine for each patient the length of the vector
defined by the MDp;k: Lp;i ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
k
MDp;k
 2r
;
iv. establish MPTVtrend;i as the 90th percentile value of the dis-
tribution of Lp;i-values.
After calculation of MPTVtrend;i for the three principal direc-
tions, i, margins in any direction are derived from the three-
dimensional ellipsoid defined by the MPTVtrend;i.
2.G. Validation of the proposed margin recipe
The recipe for calculation of the margin component for
coping with trendline errors as described in the previous sec-
tion was validated for all 288 synthetic populations. For each
of the populations we assessed for which percentage of the
10 000 patients all trendline errors were within the calculated
margin. According to the design requirements (previous sec-
tion) this should be 90%, so only 10% of patients can have
one or more trendline errors outside the calculated margin.
Mathematically, a trendline error with components tp,i, of a
patient p, is within the calculated margin if
P3
i¼1
tp;i
MPTVtrend;i
 2
 1:
For comparison, for all synthetic populations (most of
them with time trends, see Section 2.A) we also estab-
lished the percentage of patients with all trendline errors
within the margin as calculated with the van Herk recipe.
For a population with time trends, the true random errors
are quantified by r
0
[Eq. (5)], yielding a margin for ran-
dom errors, MPTVrand ¼ 0:7r
0
(Section 2.E). However, in the
van Herk approach, trendline errors are treated as random
errors, resulting in MPTVrand ¼ 0:7r, with r defined in Eq.
(A1). As r r0 , the prescribed margin for random errors
in the van Herk approach is slightly larger than actually
required for the true random errors. For this reason, for
the van Herk approach, we established for each of the
synthetic populations the percentage of patients with all
trendline errors inside an ellipsoid defined by the margin
components 2:5Ri þ 0:7 ri  r0i
 
.
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2.H. An analytical expression for the novel CTV-
PTV margin
Section 2.F describes a numerical procedure for deriving
the CTV-PTV margin, given the trendline characterization of
the setup errors in the patient population. For populations
with Mi = 0 and Ma,i = 0, that is, assuming that on average
the patients’ systematic setup errors and trendline slopes are
zero, we also derived an analytical expression for the margin.
To this purpose, margins calculated with the method pre-
sented in Section 2.E were fit to Eq. (7). The least square
method as implemented in the SciPy package was used to
establish the values for the fitting parameters a, d, and c.
MPTVtrend;iðMi ¼ 0;Ri;Ma;i ¼ 0;Ra;i;FÞ
¼ a  Ri þ RA;i
 þ d Ri  RA;iﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
R2i þ c  Ri  RA;i þ R2A;i
q (7)
with RA;i ¼ F  1ð Þ  Ra;i=2, the standard deviation describ-
ing the distribution of trend motions during one-half of the
fractions.
2.I. Origin of time trend errors
We propose a statistical method to determine whether
observed trends in a population are caused by limited numbers
of fractions or and by other (e.g., physiological) causes. First,
for a large number of patients (106) setup errors are randomly
generated for fractionated treatments, usingM, R, r, and SDSD
(i.e., ignoring trendline parameters). For all simulated
patients, trendlines are then fitted. Next, the distribution of
trendline slopes obtained from the simulations is compared to
the distribution of slopes derived from the original (i.e., clini-
cal) data using the Kolmogorov–Smirnov two-sample test.
3. RESULTS
3.A. Characterization of setup errors in the
Erasmus database
Figure 2 shows for the three principal directions the distri-
butions of total trend motion in the fractionated treatments.
Absolute total trend motion for 10% of patients was larger
than 2.6, 5.2, and 5.3 mm for left–right, superior–inferior,
and anterior–posterior directions, respectively. Table I shows
both the conventional characterization and the trendline char-
acterization for the setup errors in the Erasmus database.
Results of the test proposed in Section 2.I showed that
observed trends in the Erasmus database are indeed larger
than expected from the finite number of fractions
(P < 0.001).
3.B. Monte Carlo simulations of residual setup
errors for NAL and eNAL
For patient populations with time trends we investigated
the impact of using a conventional characterization of setup
errors for establishment of the distribution of residual system-
atic errors, Rres, instead of the more precise trendline charac-
terization. Simulations were performed both for synthetic
populations and for the measured errors in the Erasmus data-
base. Always, the NAL/eNAL protocols were also simulated
by directly using the fraction setup errors, that is, not using
any characterization as an intermediate step. The latter simu-
lations reflect the ground truth regarding the reduction of sys-
tematic setup errors with NAL/eNAL. For synthetic
populations, a schematic overview of the investigations is
provided in Fig. 3.
3.B.1. NAL for synthetic populations
For all synthetic populations, the investigations demon-
strated that the simulations based on trendline
FIG. 2. Distributions of total trend motion, defined as the trendline error of a
patient in the last fraction minus the trendline error in the first fraction, in the
Erasmus database along the principal directions. [Color figure can be viewed
at wileyonlinelibrary.com]
TABLE I. Conventional and trendline characterizations of uncorrected setup errors in the Erasmus database. See Eqs. (1)–(6) and (A1)–(A2) for definition of the
parameters. M and R are part of both characterizations. Trendline slope parameters,Ma, Ra are given in mm/fraction. All other values are given in mm.
Conventional characterization
Trendline characterization
r SDSD M R Ma Ra r0 SD
0
SD
Left–right 1.93 0.71 0.32 2.50 0.002 0.046 1.86 0.69
Superior–inferior 2.64 0.68 0.97 3.37 0.042 0.075 2.45 0.60
Anterior–posterior 2.77 0.80 0.54 3.47 0.019 0.083 2.59 0.72
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characterization did indeed accurately predict Rres, that is,
the values were close to the ground truth values. In con-
trast, the use of conventional characterization did often
result in significant deviations in estimated Rres. For all
populations with Ra[ 0:05, the simulation based on the
conventional characterization overestimated the reductions
in systematic setup errors with the NAL protocol. For
N = 3, that is, imaging in the first three fractions, results
for 12 out of 144 synthetic populations are summarized
in Fig. 4. For these populations, the mean difference
between the simulated Rres based on the trendline charac-
terization and the ground truth value was
0:01 0:02mm. For simulated Rres based on conven-
tional characterization of trendline errors the difference
was 0:4 0:5mm.
3.B.2. eNAL for synthetic populations
Similar to the simulations for the NAL protocol, Rres esti-
mated with the use of trendline characterization agreed very
well with the ground truth (mean difference for N = 3:
0:01 mm 0:1 mm). Different from NAL, for eNAL simu-
lations done with conventional characterization underesti-
mated the positive impact of the protocol with a mean
difference in Rres of 0:2mm 0:1mm. Figure 5 shows
results for the 12 out of 144 synthetic populations. As
explained in the M&M section, eNAL was developed to
reduce residual errors in populations with time trends better
than NAL. This is indeed observed when comparing the
curves for Direct simulation/Trendline MC in Fig. 5. with
those in Fig. 4.
3.B.3. NAL and eNAL for the Erasmus database
Also for the Erasmus database, the NAL simulations
based on the trendline characterization clearly agreed best
FIG. 3. Schematic overview of the investigations on Monte Carlo simulated residual setup errors for the no-action-level (NAL) and extended NAL off-line correc-
tion protocols for synthetic patient populations. * parameter values are different.
FIG. 4. Simulated residual systematic setup errors for the no-action-level pro-
tocol for 12 synthetic populations. In all simulations, imaging in only the first
three fractions was assumed. For all populations: M = 0 mm, R ¼ 3 mm
and Ma ¼ 0mm=fraction. Ra are standard deviations describing distributions
of trendline slopes.r
0
are standard deviations describing distributions of ran-
dom errors around trendlines. Direct simulation: no intermediate characteri-
zation used (ground truth), Conventional Monte Carlo (MC)/Trendline MC:
MC simulation based on a conventional/trendline characterization of the pop-
ulation setup errors. [Color figure can be viewed at wileyonlinelibrary.com]
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with the ground truth (Table II). However, the agreement
was less good than observed for the synthetic populations
(above). The eNAL simulations both for conventional and
trendline characterization agreed well with the ground
truth.
3.C. Required margins for trendline errors
Using the Python code provided in Data S1, margins
MPTVtrend;i Mi;Ri;Ma;i;Ra;i;F
 
were calculated for a wide range
of parameter values. The results are provided in Data S2 as
look-up tables.
Results of fitting Eq. (7) to data with Mi = 0 and Ma,i = 0
are presented in Table III. Differences between MPTVtrend;i calcu-
lation with the Python code and Eq. (7) are negligible. In case
of no time trends (RA;i ¼ 0), Eq. (7) reduces to the van Herk
formula for systematic setup errors with equal a-values (com-
pare columns 2 and 6 in Table III).
3.D. Validation of the proposed margin recipe for
trendline errors
The simulations described in Section 2.G demonstrated
that in the 288 synthetic populations (Section 2.C),
10:0 0:2% of patients had one or more (nonrandom) trend-
line errors outside the margin calculated with the proposed
novel recipe (y-axis Fig. 6), which is very close to the required
10.0%. In most populations, the van Herk margin for nonran-
dom errors (2:5Ri þ 0:7 ri  r0i
 
, see Section 2.G) was
clearly too small, with 58%24% of patients with one or more
trendline errors outside (x-axis Fig. 6). The largest percentages
with the van Herk approach were found for the largest popula-
tion Ma and Ravalues. The markers inside the depicted circle
in Fig. 6 belong to the simulated isotropic synthetic popula-
tions that did not have time trends. They show that our simula-
tions for the van Herk protocol (x-axis) are indeed correct, that
is, they resulted in an expected 10% of errors outside the mar-
gin. Moreover, they demonstrate that for populations without
time trends, the proposed novel recipe agrees with van Herk’s
recipe (compare x-axis with y-axis).
Table IV shows calculated margins for the Erasmus data-
base and percentages of patients with trendline error(s) out-
side. For the novel margin recipe this was 9.6%, while the
FIG. 5. Simulated residual systematic setup errors for the extended no-ac-
tion-level protocol for 12 synthetic populations. In all simulations, imaging
in the first three fractions was followed by image acquisition in the first frac-
tion of each following week. For all populations: M = 0 mm, R ¼ 3 mm and
Ma ¼ 0 mm=fraction. Ra are standard deviations describing distributions of
trendline slopes.r
0
are standard deviations describing distributions of random
errors around trendlines. Direct simulation: no intermediate characterization
used (ground truth), Conventional Monte Carlo (MC)/Trendline MC: MC
simulation based on a conventional/trendline characterization of the popula-
tion setup errors. [Color figure can be viewed at wileyonlinelibrary.com]
TABLE II. Residual systematic setup errors,Rres, for the no-action-level (NAL) and extended NAL protocols applied to the Erasmus database. All values are given
in mm. Direct simulation: no intermediate characterization used (ground truth), Conventional Monte Carlo (MC)/Trendline MC: MC simulation based on a con-
ventional/trendline characterization of the population setup errors.
NAL eNAL
Direct simulation Trendline MC Conventional MC Direct simulation Trendline MC Conventional MC
Left–right 1.4 1.2 1.1 0.8 1.1 1.0
Superior–inferior 2.0 1.7 1.3 0.8 1.1 1.0
Anterior–posterior 2.1 1.9 1.4 0.8 1.1 1.0
TABLE III. a, d and c: fit parameters for Eq. (7) as a function of the required percentage of patients (percentile) inside MPTVtrend;i. DMargin: for 441 combinations of
Ri 2 0; 5½ mm and RA;i 2 0; 5½ mm mean differences with ranges in MPTVtrend;i, calculated with exact simulation with Python code and with Eq. (7). For compar-
ison, the last column contains a-values given by van Herk et al.4
Percentile a d c DMargin (mm) a by van Herk et al.
80 2.15 0.94 0.86 2.65 9 105; [0.005, 0.004] 2.16
85 2.31 1.08 0.67 4.33 9 105; [0.006, 0.005] 2.31
90 2.50 1.27 0.52 8.19 9 105; [0.008, 0.007] 2.50
95 2.79 1.54 0.38 1.11 9 104; [0.015, 0.012] 2.79
99 3.37 2.09 0.26 1.75 9 104; [0.016, 0.019] 3.36
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van Herk recipe resulted in 23.7%. Margins calculated with
the van Herk recipe were up to 2.2 mm too small to guarantee
that not more than 10% of patients would have trendline error
(s) outside.
4. DISCUSSION
For the much applied NAL protocol for setup corrections it
was demonstrated that MC simulations based on a conven-
tional characterization overestimated the reduction in system-
atic setup errors. This is attributed to the fact that in a
conventional characterization there is no explicit modelling of
the time trends. These results demonstrate that the use of a con-
ventional characterization for simulation of setup protocols in a
patient population with trends may be potentially dangerous as
it may point at required margins that are smaller than needed.
As expected in populations with time trends, the eNAL proto-
col could better reduce setup errors than NAL. However, also
for eNAL, predicted residual errors were inaccurate when sim-
ulations were based on conventional characterization.
Based on the proposed trendline characterization of setup
errors, a novel CTV-PTV recipe for nonrandom errors was
developed, ensuring that deterministic underdosing of tumor
edges in multiple consecutive fractions as a result of trend
motion was avoided. Different from the approach proposed
by van Herk et al.,4 the nonrandom errors were not only char-
acterized by mean setup errors in fractionated treatments but
also by the slopes of fitted trendlines. Similar to the van Herk
approach, the margin for nonrandom errors was defined by
prescribing that only 10% of patients could have a non-ran-
dom error outside the calculated margin. In the absence of
time trends in the population (Ma ¼ 0 and Ra ¼ 0) the two
margins are equal. The proposed recipe describes a numerical
procedure for obtaining the margins. We derived an analytical
margin formula [Eq. (7)] in case of zero mean population
slopes and zero mean translational setup errors. We provided
a Python code (Data S1) as well as look-up tables (Data S2)
for if this is not the case.
For the proposed margin recipe we have adopted the gen-
erally applied approach of separating the total margin in two
components, one for non-random errors (described by trend-
lines) and the other for random errors, that is,
MPTV ¼ MPTVtrend þMPTVrand; where MPTVrand is used to cope with the
blurring of planned dose distributions due to random setup
errors. In this paper we have used the well-known expression,
MPTVrand ¼ 0:7r
0
.4 On the other hand, we are aware of other
recipes for calculating MPTVrand , which may be more appropri-
ate, e.g. for lung tumors or SBRT19–22. If considered appro-
priate, the applied MPTVrand ¼ 0:7r
0
can be substituted by any
other recipe. It will not impact the proposed mechanism for
calculation of MPTVtrend .
FIG. 6. For the 288 synthetic patient populations and the Erasmus database,
percentages of patients with trendline error(s) outside the three-dimensional
clinical target volume (CTV)–planning target volume (PTV) margin for non-
random errors. X- axis: percentages for margins according to van Herk et al.,
Y-axis: percentages according to the proposed novel recipe. [Color figure can
be viewed at wileyonlinelibrary.com]
TABLE IV. Calculated margins and percentages of patients with one or more
trendline errors outside, in case no setup protocols applied. To calculate total
margins, 0:7r
0
is added to the margin for nonrandom errors, see Section 2.G.
Margin — van Herk
recipe nonrandom/total
Margin — proposed
recipe nonrandom/total
Left–right 6.3/7.6 mm 7.5/8.8 mm
Superior–inferior 8.6/10.3 mm 10.8/12.5 mm
Anterior–posterior 8.8/10.6 mm 11.0/12.8 mm
% patients
outside 3D margin
23.7% 9.6%
FIG. 7. Population r fð Þ of setup errors for patients in the Erasmus database.
For each patient, the standard deviation for each fraction, f, was established
from the measured setup errors in the fractions f-2, f-1, and f. For each frac-
tion, f, these patient-specific standard deviations, SDp(f), were then combined
into a r fð Þ [see Eq. (A1)] as presented along the y-axis. [Color figure can be
viewed at wileyonlinelibrary.com]
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To the best of our knowledge there is no radiobiological or
clinical literature that confirms or denies a need for avoiding
systematic underdosing of tumor edges in multiple consecu-
tive fractions that can result from trend motion. Therefore,
there is possibly no need, or not always a need, to (fully)
apply the enlarged margins following from the proposed
CTV-PTV margin recipe. On the other hand, as the recipe
uses distributions of combined errors, MDp (Section 2.F),
resulting from systematic errors (mp) and trends (ap) (so no
separate distributions of errors resulting from mp and from
ap, i.e., no addition of margins), the margin increase com-
pared to the van Herk approach may in practice be limited
(see, e.g., Table IV; 7.6 mm compared to 8.8 mm). Neverthe-
less, as margin increases can result in increased OAR doses,
there can be arguments to choose for the original van Herk
margin recipe. Alternatively, margins could be calculated
with the novel recipe while allowing some underdose in
specific areas of the extended PTV that would otherwise
result in unacceptable enhancement of OAR doses. In any
way, systematic radiobiological studies are warranted to guide
future clinical decisions regarding the margin in case of time
trends. As described elsewhere in this section, also if
enlarged margins would not be needed, there are still other
arguments to apply trendline characterizations instead of the
conventional fractionation in case time trends occur in the
patient population.
Both in conventional and in trendline characterizations of
setup errors there is a decoupling of random and nonrandom
errors. This decoupling may result in erroneous conclusions
from MC simulations. We have proposed correction schemes
to avoid these issues (Section 2.D).
As explained in Section 2.D, even in populations that
would not have systematic setup errors or time trends in case
of an infinite number of treatment fractions, such errors and
time trends are to be expected if the same patients would be
treated with a (more realistic) finite number of fractions. A
test has been proposed to find out whether observed time
trends in a population are related to the finite number of frac-
tions or whether there are other (physiologic) causes for
observed trends (Section 2.I).
For the investigated synthetic patient populations, MC
simulations using trendline characterization resulted in highly
accurate residual setup errors after NAL corrections. For
N = 3 the difference in Rres with the ground truth was
0:01 0:02 mm. For the Erasmus database, ground truth
Rres values were up to 0.3 mm larger than those obtained
with MC simulations based on trendline characterization,
depending on direction (see Table II). Part of the explanation
for enhanced ground truth residual errors may be found in
Fig. 7, showing r fð Þ values calculated with Eq. (A1) for
patients’ standard deviations in setup errors calculated over
three fractions (SDp fð Þ). It shows for the superior–inferior
and anterior–posterior directions enhanced standard devia-
tions at the start of treatment. In the ground truth simulations
for NAL this is expected to result in increased Rres as the
mean setup errors determined in the first three fractions, used
for set-up corrections in the following fractions, may deviate
more from the true mean set-up errors due to the larger ran-
dom errors at the start of treatment. To investigate this fur-
ther, we also performed direct simulations with set-up errors
that were inverted in time, that is, fraction F ! fraction 1,
fraction F  1 ! fraction 2, etc. For the inverted fraction
order, the achieved Rres indeed reduced: from 1.4 to 1.2 mm,
from 2.0 to 1.6 mm, and from 2.1 to 1.8 mm for left–right,
superior–inferior, and anterior–posterior directions, respec-
tively. The new Rres do better agree with the MC predictions
for trendline characterization, that is, 1.2, 1.7, and 1.9 mm,
respectively (see Table II). The observed enhanced variation
in setup errors at the start of treatment could be related to
patients being more nervous at the start, rather than at later
moments in the fractionated treatment.
Currently, many patients are treated with daily online
setup corrections.23,24 Obviously, this approach can reduce
the occurrence of time trends. However, in case of differen-
tial motion between various targets this may not be the case.
For example, time trends have been observed for the
lumpectomy cavity in breast cancer patients12 for primary
larynx tumors13 and for lung.14 However, for these patient
groups, the surrounding nodal targets do not move with the
primary target. Therefore, correction of time trends in these
targets based on daily setup corrections can induce effective
time trends in the setup of the surrounding nodes. The pro-
posed margin recipe can then be used for margin definition
for the nodes. In that case, setup errors of nodes have to be
described relative to the tumor center of mass. Such a proce-
dure has to be further evaluated and verified prior to clinical
implementation.
Probabilistic/robust planning does not need margins.
However, it is based on distributions of geometric uncer-
tainties in patient populations.25–27 To the best of our
knowledge, explicit inclusion of time trends in probabilistic
planning has not yet been investigated. It would add an
extra complexity to the plan generation. It would also need
rethinking the probability requirements for CTV coverage
in case the probability of deterministic underdosing parts of
the CTV in multiple consecutive fractions needs to mini-
mized. On the other hand, we hypothesize that using trend-
line characterizations of setup errors in patient populations
that have time trends may improve the robustness of the
generated plans. Further research is needed to investigate
the full consequences of explicit inclusion of time trends in
probabilistic planning.
5. CONCLUSIONS
The conventional characterization of tumor setup errors
in patient populations, using only distributions of random
and systematic errors, has limitations for populations with
interfraction time trends. We have investigated the use of
the trendline characterization that explicitly models these
time trends. Trendline characterization resulted in more
accurate simulated residual setup errors after the applica-
tion of offline setup correction protocols, avoiding the
application of erroneous margins. The proposed novel
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CTV-PTV margin recipe for nonrandom errors can be used
to avoid or reduce underdosing of tumor edges in multiple
consecutive fractions caused by trend motions. In the limit
of the absence of time trends in a population, the margin
recipe reduces to the well-known van Herk recipe for sys-
tematic errors. In case of image guided therapy for patients
with multiple targets with differential motion for daily cor-
rection of trend motion of one of the targets, the proposed
recipe may be used to calculate margins for the other tar-
gets. In probabilistic planning, use of trendline characteriza-
tion may result in more robust treatment plans. Population
analyses of interfraction setup errors need to include the
potential occurrence of time trends.
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APPENDIX A
CONVENTIONAL CHARACTERIZATION OF SET-UP
ERRORS IN A PATIENT POPULATION
Set-up errors occurring in a fractionated treatment of a
patient can be described by the mean (systematic) error
during the treatment, and day-to-day variations around the
mean (random errors). Observed systematic and random
errors are used to derive population parameters that charac-
terize the error distributions along the principal directions
i.e. anterior-posterior, superior-inferior, left-right. The fol-
lowing population parameters are established for each
direction:
• the overall mean set-up error M in the population – see
Eq. 1
• the standard deviation R describing the distribution of
systematic (i.e. mean) set-up errors in the population –
see Eq. 2
• the population standard deviation describing the ran-
dom errors:
r ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
p
SD02p
N
q
(A1)
with SDp the standard deviation of the random set-up
errors observed for patient p
• the standard deviation describing the variation of SDp
in the population15:
SDSD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
p
SDpSDpð Þ2
N1
s
(A2)
In most publications SDSD is not reported. This is related
to the fact that in two well-known CTV-PTV margin recipes
by van Herk et al.4 (MPTV ¼ 2:5Rþ 0:7r) and by Stroom5
(MPTV ¼ 2:0Rþ 0:7r) random errors are described only by
r as defined in Eq. A1.
APPENDIX B
CORRECTIONS DONE FOR MC SIMULATIONS
BASED ON CONVENTIONAL CHARACTERIZATION
Corrected random set-up errors in the F fractions of the
fractionated treatment of a patient p were established in a 3-
step process:
i. randomly select the standard deviation of the patient’s
random set-up errors, SDp, from the distribution
G r; SDSDð Þ;
ii. randomly select F random setup errors from the distri-
bution G 0; SDp
 
and determine the mean of these
errors, mrp, where r stands for random;
iii. subtract mrp from the random errors established in ii.
CORRECTIONS DONE FOR MC SIMULATIONS
BASED ON TRENDLINE CHARACTERIZATION
Analogous to the conventional characterization, correc-
tions were made to the MC generated random errors. To this
purpose, for each patient, F random errors were first ran-
domly selected from the distribution G 0; SD0p
 
, with SD0p
drawn from G r0; SD0SD
 
. Then, an auxiliary trendline was
fitted through these errors. This line was then used to correct
the initially selected random errors such that the overall mean
and the time trend slope of the corrected random errors both
became zero. In this way, a random selection of a finite num-
ber (F ¼ 39) of random errors would not result in an unde-
sired effective change in the patient’s trendline drawn from
G M;Rð Þ and G Ma;Rað Þ.
APPENDIX C
DESCRIPTION OF THE NO ACTION LEVEL (NAL)
AND EXTENDED NAL PROTOCOLS
The much applied NAL protocol2 is based on off-line
establishment of set-up corrections to be applied in future
fractions. During the first N fractions (usually N ¼ 3) of the
patient’s treatment, images are taken and no corrections are
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applied. After fraction N, the mean set-up error during the
first N fractions is calculated, which is considered as an esti-
mate of the patient’s mean (= systematic) set-up error in case
no corrections would be applied. From fraction N þ 1 till the
last fraction, the patient is first set up on the original tattoos
and then shifted by –(mean set-up error in first N fractions)
using couch translations. The dose is then delivered without
further imaging. Aim of this protocol is to reduce systematic
set-up errors while random errors are not affected.
In 2007 an extended version of the NAL protocol (eNAL3)
was proposed to also deal with set-up changes that can occur
during a fractionated treatment, such as time trends. In the
first week of treatment, eNAL is equal to NAL. In each sub-
sequent week, the set-up correction vector is updated using
set-up errors measured in its first fraction.
a)Author to whom correspondence should be addressed. Electronic mail:
m.gizynska@erasmusmc.nl.
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SUPPORTING INFORMATION
Additional supporting information may be found online in
the Supporting Information section at the end of the article.
Data S1. Python script for margin calculation.
Data S2. Tables containing margin sizes for different
parameters.
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